ArticleActa neuropathologica2022
Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions.
Open access · greenAbstract read
In one paragraph
Article in Acta neuropathologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.
- CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.Acta neuropathologica communications · 2023Pooled it
- AOSNP-ADAPTR resource level-based recommendations on practical diagnostic strategies for ependymomas.Brain pathology (Zurich, Switzerland) · 2026Article
- CNS tumor type prevalence according to age group: An analysis of 21 000 cases confirmed by methylation profiling, with a focus on adolescents and young adults.Neuro-oncology · 2026Article
- Intracranial mesenchymal tumor, FET::CREB fusion-positive: An integrative analysis of 81 cases.Neuro-oncology · 2026Article
- Case Report: High-grade supratentorial CNS neoplasm withFrontiers in oncology · 2026Article
- BCOR loss promotes both retinoblastoma growth and susceptibility to IGF1R inhibition.Neuro-oncology · 2025Article
- CNS Tumor with BCOR/BCORL1 Fusion: A Rare Tumor Entity.International journal of molecular sciences · 2025Article
- A novel KDM2A::YAP1 fusion in a pediatric supratentorial CNS neoplasm resembling a tumor with BCOR internal tandem duplication.Free neuropathology · 2025Article
- BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.Acta neuropathologica communications · 2024Review
- CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors.Acta neuropathologica communications · 2024Article
- Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation.Brain tumor pathology · 2024Article
- Report two adult cases of high-grade neuroepithelial neoplasm harbouring EP300::BCOR fusions with comprehensive molecular detection.Brain pathology (Zurich, Switzerland) · 2023Article
- High-grade neuroepithelial tumor with EP300::BCOR fusion and negative BCOR immunohistochemical expression: a case report.Brain tumor pathology · 2023Article
- Isocitrate Dehydrogenase-Mutant WHO Grade 4 Astrocytoma with BCOR Alteration: Case Report.Case reports in oncologyArticle
- cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics.Neuro-oncology advancesReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors at 19 institutions in 4 countries.
Zhichao WuLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Sharika RajanLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Hye-Jung ChungLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Mark RaffeldLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Pavalan Panneer SelvamLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Leonille SchweizerDepartment of Neuropathology, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Arie PerryDepartment of Pathology, University of California, San Francisco, CA, USA.
David SamuelDepartment of Oncology, Valley Children's Hospital, Madera, CA, USA.
Caterina GianniniDepartment of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.
Aditya RagunathanDepartment of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.
Matthew P FroschC.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Michael S MarshallC.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Daniel R BouéDepartments of Pathology and Laboratory Medicine, Nationwide Children's Hospital and The Ohio State University Columbus, Columbus, OH, USA.
Kliment DonevDepartment of Pathology and Laboratory Medicine, Mayo Clinic, Scottsdale, AZ, USA.
Stewart G NeillDepartment of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Igor FernandesLaboratorio Bacchi, São Paulo, Brazil.
Adam ResnickCenter for Data Driven Discovery in Biomedicine (D3B), Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Brian RoodCenter for Cancer and Immunology, Brain Tumor Institute, Children's National Health System, Washington, DC, USA.
Thomas J CummingsDepartment of Pathology, Duke University Medical Center, Durham, NC, USA.
Anne F BuckleyDepartment of Pathology, Duke University Medical Center, Durham, NC, USA.
Linda SzymanskiDepartment of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Osorio Lopes Abath NetoDepartment of Pathology, University of Iowa, Iowa City, IA, USA.
Leor ZachSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Howard ColmanDepartment of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Samuel CheshierDivision of Pediatric Neurosurgery, Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Intermountain Primary Children's Hospital, Salt Lake City, UT, USA.
Jennifer ZiskinKaiser Permanente Hospital, Redwood City Medical Center, Redwood City, CA, USA.
Manoj TyagiLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
David CapperDepartment of Neuropathology, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Zied AbdullaevLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Patrick J CiminoSurgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Martha QuezadoLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Drew PrattLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Kenneth AldapeLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. kenneth.aldape@nih.gov.ORCID http://orcid.org/0000-0001-5119-7550
National Institutes of Health · USMayo Clinic in Arizona · USDuke Medical Center · USHarvard University · USChildren's Hospital Central California · USChildren's Hospital of Los Angeles · USChildren's Hospital of Philadelphia · USChildren's National · USEmory University · USGerman Cancer Research Center · DEHumboldt-Universität zu Berlin · DEKaiser Permanente Redwood City Medical Center · USLaboratório Bacchi · BRNationwide Children's Hospital · USPrimary Children's Hospital · USTel Aviv University · ILUniversity of California, San Francisco · USUniversity of Iowa · USUniversity of Utah · US
Funding
Single-cell DNA methylation analysis of human cancerZIABC011846 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ALDAPE, KENNETH · 2018 to 2025
$8.4MIntramural NIH HHS ZIA BC011846
Abstract
PubMed holds no abstract for this paper.
Indexed as
GliomaE1A-Associated p300 ProteinHumansProto-Oncogene ProteinsRepressor ProteinsBCOR protein, humanE1A-Associated p300 ProteinEP300 protein, humanProto-Oncogene ProteinsRepressor Proteins
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.